Clinical Application of New Software for the Diagnosis and Treatment of Postpartum Hemorrhage

doi:10.12114/j.issn.1007-9572.2019.00.162

Abstract

Abstract: Background　Postpartum hemorrhage is the leading cause of maternal mortality worldwide accounting for 19.7% of all maternal deaths，which threatens maternal lives seriously.Objective　To explore the clinical application value of the new software for diagnosis and treatment system of postpartum hemorrhage（diagnosis and treatment system）based on fuzzy theory in obstetrics.Methods　A total of 426 patients with postpartum hemorrhage were collected from the Department of Obstetrics and Gynecology of the Second Affiliated Hospital of Nanjing Medical University from 1st May 2015 to 1st May 2017.Their basic information was recorded into the new software to predict the risk of postpartum hemorrhage and its related causes.The predicted results were compared with the actual occurrences，and the actual amount of bleeding was recorded.Results　The risk of postpartum hemorrhage and causes of bleeding predicted by the diagnosis and treatment system software were consistent with the actual occurrences（P>0.05）．The software predicted postpartum hemorrhage with low and medium risks was mainly due to uterine inertia，accounting for 100.0% and 79.3% respectively.The main causes of postpartum hemorrhage with high risk were uterine inertia and placental factors，accounting for 60.5% and 31.4%.Placental factors were the main causes of postpartum hemorrhage with an extremely high risk，accounting for 71.6%.There was a significant difference in the amount of bleeding among patients by diagnosis and treatment system with different postpartum hemorrhage risks（F=241.64，P<0.01）．Among them，the amount of bleeding of patients with medium，high and extremely high risks were more than that of patients with low risk，and as the risk increased，the amount of bleeding increased（P<0.05）．Conclusion　The software for the diagnosis and treatment system of postpartum hemorrhage based on fuzzy theory can accurately assess the risk of postpartum hemorrhage and the causes of bleeding and its predicted results of amount of bleeding with different risks were close to the clinical results，which make it high application value in clinical work.

Key words: Postpartum hemorrhage, Fuzzy theory, Diagnosis, Therapy, Software, Forecasting

摘要： 背景　产后出血是全球范围内引起孕产妇死亡的首要原因，占全世界孕产妇死亡原因的19.7%，严重威胁着孕产妇的生命安全。目的　探讨基于模糊理论的新型产后出血诊疗系统软件（简称诊疗系统软件）在产科的临床应用价值。方法　选取2015-05-01至2017-05-01在南京医科大学第二附属医院住院分娩且发生产后出血的426例产妇为研究对象，录入基于模糊理论的诊疗系统软件，将诊疗系统软件预测的产后出血风险、出血原因与实际发生情况进行比较，记录实际出血量。结果　诊疗系统软件预测的产后出血风险、出血原因与实际情况比较，差异无统计学意义（P>0.05）。诊疗系统软件预测的低、中度产后出血风险产妇的产后出血原因主要为宫缩乏力，分别占100.0%和79.3%；高度产后出血风险产妇的产后出血原因主要为宫缩乏力和胎盘因素，分别占60.5%和31.4%；极高度产后出血风险产妇的产后出血原因主要为胎盘因素，占71.6%。诊疗系统软件预测的不同产后出血风险产妇实际出血量比较，差异有统计学意义（F=241.64，P<0.01）；其中，诊疗系统软件预测的中、高、极高度产后出血风险产妇实际出血量多于低度产后出血风险产妇，高、极高度产后出血风险产妇实际出血量多于中度产后出血风险产妇，极高度产后出血风险产妇实际出血量多于高度产后出血风险产妇（P<0.05）。结论　基于模糊理论的诊疗系统软件能准确评估产后出血风险、出血原因，不同产后出血风险出血量预测结果接近临床实际，在临床工作中具有较高应用价值。

关键词: 产后出血, 模糊理论, 诊断, 治疗, 软件, 预测

XU Songyuan,LIANG Shenglian,CAO Lixia, et al. Clinical Application of New Software for the Diagnosis and Treatment of Postpartum Hemorrhage　[J]. Chinese General Practice, 2019, 22(30): 3726-3730. DOI: 10.12114/j.issn.1007-9572.2019.00.162.
徐崧圆,梁升连,曹丽霞等. 新型产后出血诊疗系统软件的临床应用[J]. 中国全科医学, 2019, 22(30): 3726-3730. DOI: 10.12114/j.issn.1007-9572.2019.00.162.

References

［1］GOFFMAN D，NATHAN L，CHAZOTTE C.Obstetric hemorrhage：a global review［J］．Semin Perinatol，2016，40（2）：96-98．DOI：10.1053/j.semperi.2015.11.014.
［2］刘兴会，陈锰.全球产后出血指南异同［J］．中国实用妇科与产科杂志，2017，33（6）：556-559．DOI：10.19538/j.fk2017060102.
LIU X H，CHEN M.Comparisons of global postpartum hemorrhage guidelines［J］．Chinese Journal of Practical Gynecology and Obstetrics，2017，33（6）：556-559．DOI：10.19538/j.fk2017060102.
［3］刘兴会，张力，张静.《产后出血预防与处理指南（草案）》（2009）及《产后出血预防与处理指南（2014年版）》解读［J］．中华妇幼临床医学杂志（电子版），2015，11（4）：433-447．DOI：10.3877/cma.j.issn.1673-5250.2015.04.002.
［4］马苏亚.软产道裂伤致产后出血的临床分析［J］．中国社区医师，2017，33（33）：62，64．DOI：10.3969/j.issn.1007-614x.2017.33.35.
MA S Y.Clinical analysis of postpartum hemorrhage caused by laceration of soft birth canal［J］．Chinese Community Doctors，2017，33（33）：62，64．DOI：10.3969/j.issn.1007-614x.2017.33.35.
［5］SAY L，CHOU D，GEMMILL A，et al．Global causes of maternal death：a WHO systematic analysis［J］．Lancet Glob Health，2014，2（6）：e323-333．DOI：10.1016/S2214-109X（14）70227-X.
［6］SENTILHES L，MERLOT B，MADAR H，et al．Postpartum haemorrhage：prevention and treatment［J］．Expert Review of Hematology，2016，9（11）：1043-1061．DOI：10.1080/17474086.2016.1245135.
［7］KOEN S，SNYMAN L C，PATTINSON R C，et al．A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section［J］．S Afr Med J，2016，106（4）：55-56．DOI：10.7196/SAMJ.2016.v106i4.10133.
［8］QUIBEL T，GHOUT I，GOFFINET F，et al．Active management of the third stage of labor with a combination of oxytocin and misoprostol to prevent postpartum hemorrhage：a randomized controlled trial［J］．Obstet Gynecol，2016，128（4）：805-811．DOI：10.1097/AOG.0000000000001626.
［9］VALLERA C，CHOI L O，CHA C M，et al．Uterotonic medications：oxytocin，methylergonovine，carboprost，misoprostol［J］．Anesthesiol Clin，2017，35（2）：207-219．DOI：10.1016/j.anclin.2017.01.007.
［10］钱夏柳，詹泽森，覃惠凤．以新产程标准为指导的产程处理对分娩结局的影响研究［J］．中国全科医学，2017，20（15）：1845-1848．DOI：10.3969/j.issn.1007-9572.2017.15.012.
QIAN X L，ZHAN Z S，QIN H F．Effect of labor treatment guided by the new labor standard on the delivery outcome［J］．Chinese General Practice，2017，20（15）：1845-1848．DOI：10.3969/j.issn.1007-9572.2017.15.012.
［11］方春丽，冷雯，姜洪苗，等．卡孕栓减少剖宫产术后出血及促进排气、排尿功能恢复的临床效果［J］．江苏医药，2017，43（14）：998-1000．DOI：10.19460/j.cnki.0253-3685.2017.14.005.
FANG C L，LENG W，JIANG H M，et al．Clinical efficacy of carboprost in reducing postpartum bleeding and promoting recovery of postoperative exhaust and urination function after Cesarean section［J］．Jiangsu Medical Journal，2017，43（14）：998-1000．DOI：10.19460/j.cnki.0253-3685.2017.14.005.
［12］Society of Gynecologic Oncology，American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine，CAHILL A G，et al．Placenta accreta spectrum［J］．Am J Obstet Gynecol，2018，219（6）：B2-16．DOI：10.1016/j.ajog.2018.09.042.
［13］高同锁，王学静，贾广志，等．经导管动脉栓塞术治疗重度产后出血22例临床分析［J］．疑难病杂志，2016，15（1）：84-86．DOI：10.3969/j.issn.1671-6450.2016.01.021.
GAO T S，WANG X J，JIA G Z，et al．Embolization therapy for Severe postpartum hemorrhage：22 cases report［J］．Chinese Journal of Difficult and Complicated Cases，2016，15（1）：84-86．DOI：10.3969/j.issn.1671-6450.2016.01.021．
［14］张斌.基于模糊C均值聚类法的医学X片图像分割［J］．电脑知识与技术，2017，13（34）：224-225．DOI：10.14004/j.cnki.ckt.2017.3899.
ZHANG B.The segmentation of medical radiograph based on fuzzy C-means clustering method［J］．Computer Knowledge and Technology，2017，13（34）：224-225．DOI：10.14004/j.cnki.ckt.2017.3899.
［15］葛海艳，应小燕.最佳避孕方法电脑模糊综合评判软件应用后问卷调查［J］．江苏医药，2011，37（10）：1214-1216．DOI：10.19460/j.cnki.0253-3685.2011.10.041.
［16］褚志平，刘雅雯，梁升连，等．1707例产后出血患者产前高危因素及出血原因分析［J］．中国医药导报，2013，10（26）：55-57，60．DOI：10.3969/j.issn.1673-7210.2013.26.019.
CHU Z P，LIU Y W，LIANG S L，et al．Analysis of high risk factors and causes of 1707 cases postpartum hemorrhage［J］．China Medical Herald，2013，10（26）：55-57，60．DOI：10.3969/j.issn.1673-7210.2013.26.019.
［17］梁升连，葛海艳，褚志平，等．重度产后出血232例相关因素分析［J］．中华临床医师杂志：电子版，2013，7（22）：10350-10353．DOI：10.3877/cma.j.issn.1674-0785.2013.22.125.
［18］焦军彩，应小燕，王函.基于模糊理论的产后大出血风险预测［J］．数学的实践与认识，2012，42（23）：129-137．DOI：10.3969/j.issn.1000-0984.2012.23.016.
JIAO J C，YING X Y，WANG H.The risk forecast of postpartum hemorrhage based on fuzzy theory［J］．Mathematics in Practice and Theory，2012，42（23）：129-137．DOI：10.3969/j.issn.1000-0984.2012.23.016.

[1]	ZHANG Peng, LIU Lidi, ZHANG Ying, YANG Ziyu, LIU Changming, TANG Yijun, LIAO Xiaoyang, JIA Yu. Interpretation and Clinical Implications of the 2024 Italian Guidelines for the Management of Adult Individuals with Overweight and Obesity and Metabolic Comorbidities That are Resistant to Behavioral Treatment [J]. Chinese General Practice, 2025, 28(30): 3747-3752.
[2]	LI Hao, LI Peijin, LIU Tingting, CUI Yiyuan, LI Sicong, LIU Lixing, FENG Li, Working Group on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment Guidelines for Cancer Pain. Guidelines on the Diagnosis and Treatment of Cancer Pain by Integrated Traditional Chinese and Western Medicine [J]. Chinese General Practice, 2025, 28(30): 3729-3740.
[3]	ZHANG Tianyu, YU Haibo, CHEN Fei, LI Xin, ZHANG Jiajia, ZHAN Xiaokai, SHEN Man, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia. Meta-analysis of the Efficacy and Safety of Systemic Treatment for POEMS Syndrome [J]. Chinese General Practice, 2025, 28(27): 3447-3455.
[4]	WANG Yajing, DUAN Xiaoyang, HOU Ran, HUANG Yajie, SHI Jian. Advances in Targeted Combination Therapy for Patients with Brain Metastases from EGFR-mutated Non-small Cell Lung Cancer [J]. Chinese General Practice, 2025, 28(26): 3328-3337.
[5]	HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344.
[6]	YIN Jiahui, YANG Xinhui, WANG Jingjing, ZHANG Yajing, WANG Lijuan, FU Zuodi, KONG Xiangshuang, GUO Guangxia, LI Yufeng. Predictive Value Waist-to-height Ratio, Waist-to-hip Ratio and Body Mass Index for Metabolic Syndrome [J]. Chinese General Practice, 2025, 28(26): 3258-3263.
[7]	WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276.
[8]	ZHI Congcong, LI Xue, CHENG Yicheng, WANG Xiaolong, ZHENG Lihua. Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Hemorrhoids (2025 Edition) [J]. Chinese General Practice, 2025, 28(26): 3217-3228.
[9]	PAN Qi, REN Jingjing, MA Fanghui, HU Mengjie. Survey of General Practitioners' Cognition and Needs for AI Assisted Diagnosis and Treatment Systems [J]. Chinese General Practice, 2025, 28(25): 3127-3136.
[10]	LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999.
[11]	RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960.
[12]	YANG Handan, QIAO Wen, HE Shu, CHEN Yi, TONG Yunmei. The Impact of Acceptance and Commitment Therapy Combined with Sertraline on Depressive Mood, Suicidal Ideation, and Sleep Quality of Adolescents with Depression [J]. Chinese General Practice, 2025, 28(22): 2813-2818.
[13]	WANG Ying, YAN Yijun, LIU Lei, HU Yumin, ZHANG Yang, LIU Kai, JIANG Boren. Effects of Resistance Exercise Combined with Nutritional Intervention on Blood Glucose Stability in Elderly Patients with Type 2 Diabetes Mellitus with Sarcopenia [J]. Chinese General Practice, 2025, 28(21): 2604-2610.
[14]	Chinese Geriatrics Society, General Practice Branch of Zhejiang Medical Association, the Expert Collaboration Group on Medically Unspecified Disease in General Practice. Expert Consensus on the Diagnosis, Treatment, and Management of Emaciation (2025) [J]. Chinese General Practice, 2025, 28(21): 2577-2594.
[15]	YANG Jiang, LI Jiansheng, CHEN Yaolong, LIU Huiguo, WANG Jianxin, YU Jiajie, LI Huiru, XIAO Qionghua, XIE Yang, LI Suyun, WANG Minghang. Guideline on Treating Adult Community-acquired Pneumonia with Chinese Patent Medicines (2025 Edition) [J]. Chinese General Practice, 2025, 28(20): 2464-2480.